AtriCure Inc.

32.00
-0.08 (-0.25%)
At close: Apr 17, 2025, 3:59 PM
32.01
0.03%
After-hours: Apr 17, 2025, 04:07 PM EDT
-0.25%
Bid 31.86
Market Cap 1.58B
Revenue (ttm) 465.31M
Net Income (ttm) -44.7M
EPS (ttm) -0.95
PE Ratio (ttm) -33.68
Forward PE -76.19
Analyst Buy
Ask 41
Volume 344,526
Avg. Volume (20D) 569,483
Open 32.73
Previous Close 32.08
Day's Range 31.20 - 33.50
52-Week Range 18.94 - 43.11
Beta 1.65

About ATRC

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem...

Sector Healthcare
IPO Date Aug 5, 2005
Employees 1,300
Stock Exchange NASDAQ
Ticker Symbol ATRC
Full Company Profile

Analyst Forecast

According to 10 analyst ratings, the average rating for ATRC stock is "Buy." The 12-month stock price forecast is $50.5, which is an increase of 57.81% from the latest price.

Stock Forecasts

Next Earnings Release

AtriCure Inc. is scheduled to release its earnings on Apr 29, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-7.39%
Atricutre shares are trading lower after Canaccord... Unlock content with Pro Subscription
2 months ago
-6.54%
AtriCure shares are trading lower. The company reported Q4 financial results.